SCHEDULE 13D/A: AI Catalyst Fund Boosts Stake in ModivCare to 12%, Acquiring Additional Shares
Schedule 13D Amendment
The AI Catalyst Fund, LP and its affiliates have increased their beneficial ownership in ModivCare Inc. to 12% of outstanding common stock, acquiring an additional 312,500 shares.
Summary
- The AI Catalyst Fund, LP (AICF), The AI Catalyst Fund GP, LLC (AICF GP), and David Mounts Gonzales have filed an Amendment No. 1 to their Schedule 13D regarding ModivCare Inc.
- As of the filing date, the reporting persons beneficially own an aggregate of 1,710,000 shares of ModivCare Inc. Common Stock.
- This ownership represents approximately 12.0% of ModivCare Inc.'s outstanding shares, calculated based on 14,283,664 shares outstanding as of November 1, 2024.
- Since the initial Schedule 13D filing on January 17, 2025, AICF acquired an additional 312,500 shares.
- The aggregate purchase price for these newly acquired 312,500 shares was approximately $1,674,019, including brokerage commissions.
- The shares were purchased using working capital, which may include margin loans.
- All transactions were effected in the open market.
Sentiment
Score: 7
Explanation: The sentiment is positive as a significant investor has increased their stake in the company, indicating confidence in its value or future prospects.
Positives
- The AI Catalyst Fund has significantly increased its stake in ModivCare Inc., demonstrating increased conviction in the company.
- The acquisition of an additional 312,500 shares indicates continued investment by a notable fund.
Future Outlook
NA
Industry Context
This filing indicates a significant increase in ownership by an investment fund in ModivCare Inc., a company operating in the healthcare services sector, particularly non-emergency medical transportation. Such an increase by a substantial investor can signal a belief in the company's future prospects or potential for strategic engagement within the industry.
Stakeholder Impact
- Shareholders: The increased stake by The AI Catalyst Fund could be viewed positively, potentially signaling a vote of confidence in ModivCare's future or indicating potential for increased investor engagement.
- Company Management: A large institutional investor holding a 12% stake may exert greater influence on corporate strategy and governance.
Key Dates
| Date | Description |
|---|---|
| 2024-11-01 | Date as of which 14,283,664 shares of ModivCare Inc. Common Stock were reported outstanding in the Issuer's Quarterly Report on Form 10-Q. |
| 2024-11-07 | Date ModivCare Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2025-01-16 | Date of the Joint Filing Agreement (incorporated by reference). |
| 2025-01-17 | Date the initial Schedule 13D was filed by the Reporting Persons. |
| 2025-01-23 | Date of event which required the filing of this Amendment No. 1 to Schedule 13D. |
| 2025-01-27 | Signature date of the Amendment No. 1 to Schedule 13D. |
Keywords
ModivCare Inc., AI Catalyst Fund, Schedule 13D, Beneficial Ownership, Stock Acquisition, Institutional Investor, Healthcare Services, Non-Emergency Medical Transportation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.